EcoDrugPlus

Adrenoceptor Alpha 1d

Ensembl ID : ENSCMIG00000012686
Gene Symbol: ADRA1D
3 Cross references
196 Possible Orthologues:

Adrenoceptor Alpha 2a

Ensembl ID : ENSCMIG00000018757
Gene Symbol: ADRA2A
1 Cross references
233 Possible Orthologues:

Adrenoceptor Alpha 2b

Ensembl ID : ENSCMIG00000009848
Gene Symbol: ADRA2B
4 Cross references
222 Possible Orthologues:

Adrenoceptor Alpha 2c

Ensembl ID : ENSCMIG00000017371
Gene Symbol: ADRA2C
1 Cross references
227 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSCMIG00000010889
Gene Symbol: ADRB1
3 Cross references
163 Possible Orthologues:

Adrenoceptor Beta 2

Ensembl ID : ENSCMIG00000003155
Gene Symbol: ADRB2
4 Cross references
265 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B

Ensembl ID : ENSCMIG00000000053
Gene Symbol: AKR1B1
3 Cross references
433 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSCMIG00000018995
Gene Symbol: GAA
4 Cross references
233 Possible Orthologues:

Amine Oxidase [Flavin-Containing]-Like

Ensembl ID : ENSCMIG00000004204
Gene Symbol: LOC103177252
2 Cross references
148 Possible Orthologues:

Amine Oxidase Copper Containing 2

Ensembl ID : ENSCMIG00000003272
Gene Symbol: AOC2
3 Cross references
413 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSCMIG00000009868
Gene Symbol: AMY1C
4 Cross references
207 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSCMIG00000017578
Gene Symbol: APP
4 Cross references
279 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).